Cardiff Oncology prices equity offering at $13.50

Cardiff Oncology (NASDAQ:CRDF) has priced its public offering of 6.5M common shares at $13.50/share, for expected gross proceeds of ~$88M.

Underwriters’ over-allotment is an additional 975K shares.

Net proceeds will be used for development of product candidates, working capital and general corporate purposes.

Closing date is October 2.

Pipeline and Upcoming Catalysts:

CRDF shares have rallied more than 1000% over the past six months. Yesterday’s close was $14.01. Shares up 6% after-hours.


Leave a Reply